FDA Approvals in Oncology: April-June 2025
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
Tag: rare cancers
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
At the AACR Annual Meeting 2025, researchers shared how AACR Project GENIE is helping provide insights into rare and...
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
Recent advances in cancer research has led to enormous progress against many cancer types. From 1991 to 2015, we...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...